Allergy/immunology, dermatology, emergency medicine, and primary care physicians, nurse practitioners, and physician assistants
Hereditary angioedema
Marc Riedl, MD, MS, is professor of medicine at the University of California, San Diego (UCSD), and clinical director at the US HAEA Angioedema Center in San Diego, California. He received his medical degree from the University of Chicago–Pritzker School of Medicine, and completed a residency in internal medicine at Barnes-Jewish Hospital of Washington University in St. Louis and a fellowship in clinical immunology and allergy at University of California, Los Angeles (UCLA). Dr. Riedl received a master of science degree in clinical research and completed advanced training in clinical pharmacology at UCLA. He is board certified in internal medicine, clinical pharmacology, and allergy and immunology.
Aleena Banerji, MD, is an Assistant Professor and Assistant Training Program Director in Allergy and Immunology at Massachusetts General Hospital in Boston, Massachusetts. Dr. Banerji completed her residency in medicine at the University Hospitals of Cleveland/Case Western Reserve in Cleveland, Ohio, where she received the Charles CJ Carpenter Award for Outstanding Performance. She then went on to complete her clinical fellowship in allergy and immunology at Massachusetts General Hospital. She is board-certified in internal medicine and allergy and immunology.| 1. | Describe the epidemiology, pathophysiology, and burden of illness of hereditary angioedema (HAE) | 2. | Recognize HAE as a possible cause of recurrent angioedema and formulate an appropriate diagnostic workup for various types of HAE (Type I, Type II, and normal C1-INH) |
| 3. | Utilize individualized HAE treatment strategies, taking into consideration risks and benefits of therapies, disease characteristics and severity, comorbid conditions, patient quality of life, and patient preference |
| 1. | Describe the epidemiology, pathophysiology, and burden of illness of hereditary angioedema (HAE) |
| 2. | Recognize HAE as a possible cause of recurrent angioedema and formulate an appropriate diagnostic workup for various types of HAE (Type I, Type II, and normal C1-INH) |
| 3. | Utilize individualized HAE treatment strategies, taking into consideration risks and benefits of therapies, disease characteristics and severity, comorbid conditions, patient quality of life, and patient preference |
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |